Back to search

Article

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

2020-03-11

Abstract excerpt

<title>Abstract</title> <p>Background T cells expressing a chimeric antigen receptor (CAR) engineered to target CD19 can treat leukemia effectively but also increase the risk of complications such as cytokine release syndrome (CRS) and CAR T cell related encephalopathy (CRES) driven by interleukin-6 (IL-6). Here, we investigated whether IL-6 knockdown in CART-19 cells can reduce IL-6 secretion from monocytes, whi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a224206e-ad92-5c76-b112-6f3275eecc18
DOI
10.21203/rs.3.rs-16656/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytesDOI 10.21203/rs.3.rs-16656/v1
Select a neighboring publication to make it the new centre.